• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number UNK XIENCE SKYPOINT
Device Problems Deflation Problem (1149); Entrapment of Device (1212); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/18/2022
Event Type  Injury  
Event Description
It was reported that the procedure was to treat the right coronary artery (rca) with moderate tortuosity and mild calcification.The xience skypoint stent was implanted; however, after deployment the balloon of the delivery system would only partially deflate.There was resistance during removal and a non-abbott guide catheter extension was advanced to push the partially deflated balloon inside so it could be removed from the anatomy.The balloon was removed partially deflated.The contrast mix was 90% saline and 10% contrast and the device was not prepped (air aspiration) outside the anatomy prior to use.There were no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
The udi # is unknown due to the part/lot number was not provided.(b)(4).Product performance engineering reviewed the incident information; however, the product was not returned to abbott vascular for analysis.A review of the electronic lot history record (elhr), corrective action tracking system for the web (catsweb) database review and similar incident query for this product was not performed because the part/lot numbers were not reported.It was reported that the contrast mixture used during the procedure was 90% saline and 10% contrast.It should be noted that the xience skypoint instructions for use (ifu) states: use contrast diluted 1:1 with heparinized normal saline.In this case, it is possible that the ifu deviation contributed to the reported deflation problem.Additionally it was reported that the device was not prepared outside the anatomy.It should be noted that the ifu states: prepare an inflation device / syringe with diluted contrast medium.Attach an inflation device / syringe to the stopcock; attach it to the inflation port.With the tip down, orient the delivery system vertically.Open the stopcock to delivery system; pull negative for 30 seconds; release to neutral for contrast fill.Close the stopcock to the delivery system; purge the inflation device / syringe of all air.It is unknown if the ifu deviation(s) directly caused or contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported deflation problem; however, the reported difficult to remove and subsequent treatment appears to be related to the operational context of the procedure.Factors that may contribute to a deflation problem include, but are not limited to, contrast mixture, procedural contaminants in the inflation lumen, damage to the inflation lumen, deflation technique, and/or loose connection with the indeflator.In this case, it is possible that the contrast mixture of 90% saline and 10% contrast used during the procedure may have contributed to the reported deflation problem; however, this cannot be confirmed.Additionally, it is likely that the balloons inability to fully deflate contributed to the reported difficulty removing [entrapment] the balloon from the anatomy.There is no indication of a product quality issue with respect to manufacture, design, or labeling; therefore, no product-related corrective action will be implemented in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15780697
MDR Text Key303552464
Report Number2024168-2022-11496
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK XIENCE SKYPOINT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2022
Initial Date FDA Received11/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-